Predicting relapse in patients with inflammatory bowel disease: what is the role of biomarkers?
about
Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysisDiagnosis of inflammatory bowel disease: Potential role of molecular biometrics.Omics Approaches to Identify Potential Biomarkers of Inflammatory Diseases in the Focal Adhesion Complex.Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome.Intestinal protein expression profile identifies inflammatory bowel disease and predicts relapseNew biomarkers of Crohn's disease: serum biomarkers and development of diagnostic tools.DNA Methylation Profiling in Inflammatory Bowel Disease Provides New Insights into Disease PathogenesisS1P signaling: new therapies and opportunities.Fecal calprotectin: its scope and utility in the management of inflammatory bowel disease.Fecal calprotectin in inflammatory bowel diseases: update and perspectives.Predicting Outcomes and Tailoring Therapy in the Diagnosis and Treatment of IBD.Calprotectin and IBD.Predicting Hospitalization and Outpatient Corticosteroid Use in Inflammatory Bowel Disease Patients Using Machine Learning.The Value of Fecal Markers in Predicting Relapse in Inflammatory Bowel Diseases.New insights into the biological and clinical significance of fecal calprotectin in inflammatory bowel disease.Fecal excretion of deoxyribonucleic acid in long-term follow-up of patients with inactive ulcerative colitis.
P2860
Q24608254-D1678F47-7670-442C-8382-2F7A35D9B5EAQ27691430-D9F14BE8-3932-425A-9E2D-10308FA2062BQ33631616-0D79CCF7-5E7A-423F-853C-46728F92E0ABQ36172820-4E8B4FA8-B935-49ED-9557-AD0A55EE70B7Q36800339-1E4BD276-B8C5-4408-931C-E316412304ECQ37206175-42F4F595-407C-4CFC-8B4A-F88F79004256Q37237816-830D5100-8041-4526-8B0A-8F189F8DB466Q38314882-6DDBB705-E260-4F64-9479-07C163FD4B21Q38742261-4533152A-F610-47CA-BB63-022D2C88F3D1Q38961702-26BFC503-A78A-4DAE-B836-A096CC040909Q42233323-53151F57-BF55-402D-9031-BAD0EE812628Q43004235-31259FA1-35B5-4DCF-A7B9-4F21AC1D7CE1Q47173123-7A6CE16E-631E-4E4C-B566-588BC82BAE00Q49300617-B57668DB-F792-4CDC-9891-F30522E22F82Q51772513-B8343189-2E23-4BE8-BB61-46E06D0DED56Q54563936-70E95A12-FB6A-489F-82BB-E5271359A85F
P2860
Predicting relapse in patients with inflammatory bowel disease: what is the role of biomarkers?
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Predicting relapse in patients ...... hat is the role of biomarkers?
@ast
Predicting relapse in patients ...... hat is the role of biomarkers?
@en
type
label
Predicting relapse in patients ...... hat is the role of biomarkers?
@ast
Predicting relapse in patients ...... hat is the role of biomarkers?
@en
prefLabel
Predicting relapse in patients ...... hat is the role of biomarkers?
@ast
Predicting relapse in patients ...... hat is the role of biomarkers?
@en
P2860
P356
P1433
P1476
Predicting relapse in patients ...... hat is the role of biomarkers?
@en
P2093
W J Sandborn
P2860
P304
P356
10.1136/GUT.2004.048850
P407
P577
2005-03-01T00:00:00Z